Back to Results

Implementation of a novel protocol to measure hypothalamic insulin sensitivity in vivo in human adults

Study

Is this Study for You?

Let's Get Started!

Details
Age

Adult

Eligibility

Adults age 18-40 with no previous diagnosis of diabetes

BMI greater than 18 and less than 25 kg/m2 OR BMI greater than 27 kg/m2 No diagnosis of diabetes, pre-diabetes, polycystic ovarian syndrome, or cancer of any kind. No diagnosis of severe cognitive disabilities including Down's Syndrome, Autism Spectrum Disorder, or age-related cognitive impairment such as dementia. Not currently taking an anti-psychotic, systemic steroid, insulin sensitizing, insulin replacement therapy, or diet or weight loss medication. No MRI contraindications No use of an intrauterine device (IUD) or progesterone-only hormonal birth control, pregnancy or plans to become pregnant.

Type of Study

Observational

Locations

Brain Imaging Center (BIC)
Outpatient CTRC
University of Colorado Hospital

Principal Investigator
Allison Shapiro,  PhD, MPH

Allison Shapiro, PhD, MPH

Study ID

Protocol Number: 21-2939

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers